Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02423044 · ClinicalTrials.gov registry record
Spatial Context and Fear Learning
A clinical trial, sponsored by National Institute of Mental Health (NIMH).
- Completed
- Registry status
- 82
- Enrollment target
NCT02423044: Completed study, sponsored by National Institute of Mental Health (NIMH).
NCT02423044 is a clinical trial that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 82 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02423044 has completed, sponsored by National Institute of Mental Health (NIMH).
- COMPLETED
- Registry status
- 82 participants
- Enrollment target
Study Summary
Background: \- Fear is a normal response to a threat. Learning fear can be helpful sometimes. For people with anxiety disorders, fear can be long-lasting and too intense. Researchers want to study how people become fearful of situations. They want to understand how the brain learns when it is helpful to feel fear and when it is not. Objective: \- To better understand brain processes related to fear and anxiety. Eligibility: * Right-handed adults ages 18 50 with generalized anxiety disorder, panic disorder, social anxiety disorder, or post-traumatic stress disorder. * Right handed volunteers ages 18-50 without psychiatric disorders. * And free of psychiatric medication for 2 weeks Design: * Participants will first be screened under another protocol. * Participants will play a video game inside a magnetic resonance imaging (MRI) scanner. The scanner is a metal cylinder It is surrounded by a strong magnetic field. Participants will lie on a table that can slide in and out of the scanner. A device called a coil will be placed over the head. * During the scan, participants may play a virtual reality video game. Game instructions will be explained before they enter the scanner. * While playing the game, participants will wear 2 electrodes on their fingers. These measure sweat on the skin. They will also have 2 small electrodes attached to the left hand. These can give brief mild electrical shocks. * Participants will be asked questions when playing the game during the scan. * Before and after the scan, participants will fill out questionnaires about their emotions. They may complete questionnaires online while at the clinic.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 82 participants |
| Start Date | 2015-04-18 |
| Est. Completion | 2018-10-30 |
What the finished NCT02423044 record still lists
NCT02423044 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 82 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02423044 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02423044 about?
NCT02423044 is a clinical study titled "Spatial Context and Fear Learning". Background: \- Fear is a normal response to a threat. Learning fear can be helpful sometimes. For people with anxiety disorders, fear can be long-lasting and too intense. Researchers want to study how people become fearful of situations. They want to understand how the brain learns when it is helpf...
What is the current status of trial NCT02423044?
This trial is currently completed. The enrollment target is 82 participants. The study started on 2015-04-18. Estimated completion is 2018-10-30.
Who is sponsoring clinical trial NCT02423044?
This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03319901 · 82 participants · Phase 1
Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL
- NCT03493425 · 82 participants · Phase 2
Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery
- NCT04105270 · 82 participants · Phase 2
RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial
- NCT04428658 · 82 participants · NA
Randomized Trial of Supplemental Synchronous and Asynchronous Telehealth to Improve Glycemic Control for Pediatric Patients With Type 1 Diabetes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI